港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

生物醫藥B類股

670.135

+9.6471.46%

漲家數：17

跌家數：13

平家數：4

市盈率：- -

高：678.126

開：660.587

低：657.123

收：660.489

成交量：1.54億

成交額：46.33億

市值：4,299.47億

流通市值：3,802.52億

資料載入中...

總覽新聞資訊

歸創通橋(02190)3月30日耗資約113.73萬港元回購4.8萬股

Wellington Management Group LLP增持勁方醫藥-B(02595)約31.82萬股每股均價約30.88港元

跨國巨頭密集押注+創新藥企盈利兑現，創新藥逆市走強，520880放量連陽！MIRXES-B狂飆43%

復宏漢霖(02696)：斯魯利單抗注射液獲歐洲藥品管理局人用醫藥產品委員會積極審評意見

阿斯利康(AZN)罕見病創新藥在華獲批

李氏大藥廠(00950)發布年度業績股東應占溢利9193.8萬港元按年減少1.2%

賽克賽斯三闖IPO，專注於醫療器械領域，近5年累計派息3.23億元

同源康醫藥-B(02410)發布年度業績研發成本約2.44億元按年增加3.7%

3月30日諾誠健華漲7.08%，富國精準醫療混合A基金重倉該股

3月30日津藥藥業（600488）漲停分析：創新藥、皮質激素、出口驅動

《滬深》A股三大指數全日走個別滬指倒升鋁及創新藥股走高煤電股走低

阿斯达克财经

基石藥業－Ｂ(02616)股價上升5.042%，現價港幣$8.75

阿斯达克财经

跨國巨頭密集掃貨中國創新藥，一季度BD交易狂攬600億美元

21世纪经济报道

雲頂新耀董事長斥資3270萬港元於3月27日以每股38.12港元購入86萬股

雲頂新耀(01952)獲主要股東傅唯增持86萬股

創新藥銷售收入目標增速上調至30%以上，恒瑞醫藥憑什麼?

27.5億美元！英硅智能牽手禮來，盤初暴拉15%！港股通創新藥ETF（520880）逆市摸高2.39%！榮昌生物績後飆漲

部分創新藥概念股逆市上揚榮昌生物(09995)漲4.99%

港股榮昌生物升逾8%

每日经济新闻

315億現金「彈藥」就位，翰森製藥能否撬動全球創新藥市場？

21世纪经济报道

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1574/news?page=9"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"生物醫藥B類股","latestPrice":670.1354,"timestamp":1775117299351,"preClose":660.4887,"halted":0,"volume":153717417,"delay":0,"changeRate":0.014605,"floatShares":0,"shares":0,"eps":0,"marketStatus":"清明節翌日休市","change":9.646667,"latestTime":"04-02 16:00:00","open":660.58655,"high":678.1257,"low":657.12256,"amount":4633342498,"amplitude":0.031799,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1775611800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1775093400000,1775102400000],[1775106000000,1775116800000]],"pbRate":5.274197,"peRate":-86.845688,"turnoverRate":0.005552,"increases":17,"decrements":14,"flats":2,"marketCap":429946652416,"floatMarketCap":380251567184},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":678.1257,"amplitude":0.031799,"preClose":660.4887,"low":657.12256,"pbRate":"5.274197","latestPrice":670.1354,"volume":153717417,"delay":0,"open":660.58655,"prevYearClose":556.26263,"prevWeekClose":670.135,"prevMonthClose":610.821,"prevQuarterClose":610.821,"fiveDayClose":579.36,"twentyDayClose":522.155,"sixtyDayClose":580.971,"secType":"PLATE","market":"HK","turnoverRate":0.005552,"peRate":-86.845688,"marketCap":429946652416,"floatMarketCap":380251567184,"timestamp":1775117299351,"nameCN":"生物醫藥B類股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":17,"down":13,"flat":4},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:9,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2623317007","title":"歸創通橋(02190)3月30日耗資約113.73萬港元回購4.8萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2623317007","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623317007?lang=zh_tw&edition=fundamental","pubTime":"2026-03-30 20:25","pubTimestamp":1774873551,"startTime":"0","endTime":"0","summary":"智通财经APP讯，归创通桥(02190)公布，2026年3月30日耗资约113.73万港元回购4.8万股股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1422047.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","02190","BK1583","BK1100","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623314171","title":"Wellington Management Group LLP增持勁方醫藥-B(02595)約31.82萬股 每股均價約30.88港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2623314171","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623314171?lang=zh_tw&edition=fundamental","pubTime":"2026-03-30 19:25","pubTimestamp":1774869941,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新数据显示，3月26日，Wellington Management Group LLP增持劲方医药-B(02595)31.8247万股，每股均价30.8754港元，总金额约为982.60万港元。增持后最新持股数目约为2374.17万股，持股比例为7.02%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1421951.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1574","02595","159938","09939","EWH","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623110253","title":"跨國巨頭密集押注+創新藥企盈利兑現，創新藥逆市走強，520880放量連陽！MIRXES-B狂飆43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623110253","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623110253?lang=zh_tw&edition=fundamental","pubTime":"2026-03-30 19:10","pubTimestamp":1774869000,"startTime":"0","endTime":"0","summary":"3月30日，A港市场调整为主，创新药再度走出独立行情！100%创新药研发标的——港股通创新药ETF华宝、重仓A股创新药的药ETF逆市续涨逾1%，上一交易日，两只ETF单日大涨5.51%、4.21%，双双创下历史最大单日涨幅。　　聚焦港股通创新药日内表现，板块代表性港股通创新药ETF华宝低开高走，一度上探逾2%，最终放量收涨1%顺利连阳，全天振幅达3.61%，成交7.81亿元，续刷4个半月来新高！MIRXES-B午后突然狂飙逾43%，收涨23.69%%！","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-03-30/doc-inhsukns3956006.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159992","BK1161","02629","06978","520880","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623315758","title":"復宏漢霖(02696)：斯魯利單抗注射液獲歐洲藥品管理局人用醫藥產品委員會積極審評意見","url":"https://stock-news.laohu8.com/highlight/detail?id=2623315758","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623315758?lang=zh_tw&edition=fundamental","pubTime":"2026-03-30 17:58","pubTimestamp":1774864728,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复宏汉霖 发布公告，近日，公司自主开发的斯鲁利单抗注射液(汉斯状) 获欧洲药品管理局人用医药产品委员会积极审评意见。CHMP的审评意见将会被递交至欧盟委员会， EC将参考该意见并在未来2个月内做出最终审查决定。一旦获得EC 批准，汉斯状的集中上市许可将在所有欧盟成员国及欧洲经济区国家冰岛、列支敦士登和挪威生效。此次CHMP的积极意见主要是基于两项随机、双盲、多中心3期临床研究。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1421838.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","HK0000320223.HKD","HK0000165453.HKD","159938","02696","HK0000306685.HKD","BK1161","HK0000320264.USD","BK1515","09939","HK0000306701.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623154273","title":"阿斯利康(AZN)罕見病創新藥在華獲批","url":"https://stock-news.laohu8.com/highlight/detail?id=2623154273","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623154273?lang=zh_tw&edition=fundamental","pubTime":"2026-03-30 17:55","pubTimestamp":1774864518,"startTime":"0","endTime":"0","summary":"金吾财讯 | 阿斯利康(AZN)宣布，中国国家药品监督管理局已正式批准硫酸氢司美替尼胶囊（商品名：科赛优），用于3岁及3岁以上伴有症状、无法手术的丛状神经纤维瘤（PN）的1型神经纤维瘤病（NF1）儿童及成人患者的治疗。这是目前国内首个且唯一获批用于3岁及3岁以上该患者人群的治疗药物。","market":"us","thumbnail":"https://static.szfiu.com/news/20250107/ZDBhOTg3YTMxNzM2MjM3OTI3ODI2.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/ZDBhOTg3YTMxNzM2MjM3OTI3ODI2.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"298501","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU2236285917.USD","AZN","LU2417539215.USD","BK1574","BK4588","BK4585","LU2462157665.USD","BK4568","IE00B3T34201.USD","LU0289739699.SGD","BK1161","06978","LU0058720904.USD","LU0109394709.USD","LU1829250122.USD","LU2456880835.USD","BK4007","LU0320765992.SGD","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623318798","title":"李氏大藥廠(00950)發布年度業績 股東應占溢利9193.8萬港元 按年減少1.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623318798","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623318798?lang=zh_tw&edition=fundamental","pubTime":"2026-03-30 17:19","pubTimestamp":1774862354,"startTime":"0","endTime":"0","summary":"智通财经APP讯，李氏大药厂(00950)发布截至2025年12月31日止年度业绩，集团收益14.36亿港元，同比增长2.6%;股东应占溢利9193.8万港元，同比减少1.2%;每股盈利15.61港仙;拟派末期股息每股2.3港仙。公告称，公司拥有人应占纯利减少反映严峻市场环境及研发支出增加的合并影响，抵销了收益增长及销售费用减少所带来的裨益，导致纯利同比下滑。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1421792.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1191","BK1583","00950","BK1587","06622"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623318425","title":"賽克賽斯三闖IPO，專注於醫療器械領域，近5年累計派息3.23億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2623318425","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623318425?lang=zh_tw&edition=fundamental","pubTime":"2026-03-30 17:19","pubTimestamp":1774862351,"startTime":"0","endTime":"0","summary":"账上现金承压","market":"us","thumbnail":"https://img2.gelonghui.com/a0375-ad4d98ed-3597-4a3b-b03b-746738dc3f59.jpg?guru_height=870&guru_width=1386&guru_size=89565","type":0,"news_type":0,"thumbnails":["https://img2.gelonghui.com/a0375-ad4d98ed-3597-4a3b-b03b-746738dc3f59.jpg?guru_height=870&guru_width=1386&guru_size=89565"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4236129","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["09997","BK1100","BK1222","BK4585","BK1583","BK4588","VIG","BK1574","09996","159883"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623318523","title":"同源康醫藥-B(02410)發布年度業績 研發成本約2.44億元 按年增加3.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623318523","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623318523?lang=zh_tw&edition=fundamental","pubTime":"2026-03-30 17:01","pubTimestamp":1774861277,"startTime":"0","endTime":"0","summary":"智通财经APP讯，同源康医药-B(02410)发布截至2025年12月31日止年度业绩，研发成本约2.44亿元，同比增加3.7%;其他收入及收益3760.9万元，同比增加23.14%。于报告期间，其他收入及收益主要包括与收入相关的政府补助、与无息融资相关的政府补助以及出售一间附属公司的收益。作为一家专注于开发用于癌症治疗的小分子靶向治疗的公司，公司已建立由10款候选药物组成的管线。公司在原有组织架构基础上逐步补充商业化团队，挖掘市场潜力，不断深度挖掘产品的销售潜力并丰富品牌推广，通过参加各种学术会议、行业合作、平台合作等形式，丰富企业品牌的推广形式，提高企业品牌在行业内的知名度。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1421771.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159938","09939","02410","BK1161","BK1515","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623390532","title":"3月30日諾誠健華漲7.08%，富國精準醫療混合A基金重倉該股","url":"https://stock-news.laohu8.com/highlight/detail?id=2623390532","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623390532?lang=zh_tw&edition=fundamental","pubTime":"2026-03-30 16:31","pubTimestamp":1774859513,"startTime":"0","endTime":"0","summary":"证券之星消息，3月30日诺诚健华涨7.08%创60日新高，收盘报27.09元，换手率9.07%，成交量24.33万手，成交额6.52亿元。重仓诺诚健华的前十大公募基金请见下表：该股最近90天内共有1家机构给出评级，增持评级1家。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共13家，其中持有数量最多的公募基金为富国基金的富国精准医疗混合A。富国精准医疗混合A目前规模为28.77亿元，最新净值3.126，较上一交易日上涨6.93%，近一年上涨22.99%。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202603/30/20260330745345.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202603/30/20260330745345.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260330/32111636.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1161","BK0239","688428","BK1574","09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623239271","title":"3月30日津藥藥業（600488）漲停分析：創新藥、皮質激素、出口驅動","url":"https://stock-news.laohu8.com/highlight/detail?id=2623239271","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623239271?lang=zh_tw&edition=fundamental","pubTime":"2026-03-30 15:58","pubTimestamp":1774857514,"startTime":"0","endTime":"0","summary":"证券之星消息，津药药业3月30日涨停收盘，收盘价4.76元。今日津药药业涨停的可能因素有：创新药JYSW003银屑病项目进展顺利，药效与安全性表现良好；作为亚洲重要皮质激素原料药研发生产出口基地，泼尼松、地塞米松等多产品获美国DMF认证，出口营收占比32.42%；新获激素类滴眼剂GMP认证，设计产能2000万支/年；10个产品中选国家集采，采购周期至2028年底；公司完成原料药中心销售职能整合，强化原料药制剂一体化运营。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202603/30/20260330118071.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202603/30/20260330118071.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260330/32111462.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1574","159992","06978","BK0239","600488","BK1161","BK0012","BK0028","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623394875","title":"《滬深》A股三大指數全日走個別  滬指倒升  鋁及創新藥股走高  煤電股走低","url":"https://stock-news.laohu8.com/highlight/detail?id=2623394875","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623394875?lang=zh_tw&edition=fundamental","pubTime":"2026-03-30 15:06","pubTimestamp":1774854360,"startTime":"0","endTime":"0","summary":"A股三大指数低开高走，沪指倒升，深成及创板跌幅显著收窄。深成指全日跌34点或0.3%，报13,726点，成交1.08万亿元。创板指数全日跌22点或0.7%，报3,273点，成交4,540亿元。预计2026年油气和新能源分部的资本性支出为2,208亿元。海尔智家A股未止跌，今再跌2.9%，其2025年净利润195.53亿元，按年增长4.39%，拟10派8.867元，并拟以30亿元至60亿元回购A股股份。)相关内容《沪深两市》上证深成创板轻微低开  比亚迪及宁德时代靠稳高开AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190321150645089_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190321150645089_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1514139/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"9615512ff4faad0ac97b76bb013f2df5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1514139/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["512880","06978","BK1161","399006","BK1574","000905.SH","159967","000001.SH","000688.SH","510880","399001","510300","512510","515890","159982","159992","000300.SH","399300"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623395422","title":"基石藥業－Ｂ(02616)股價上升5.042%，現價港幣$8.75","url":"https://stock-news.laohu8.com/highlight/detail?id=2623395422","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623395422?lang=zh_tw&edition=fundamental","pubTime":"2026-03-30 13:24","pubTimestamp":1774848240,"startTime":"0","endTime":"0","summary":"[上升股]基石药业－Ｂ(02616) 股价在下午01:24比前收市价上升5.042%，现股价为港币$8.75。至目前为止，今日最高价为$8.75，而最低价为$8.25。总成交量为1.808千万股，总成交金额为港币$1.55亿。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2603302477/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2603302477/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","BK1161","02616"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623897395","title":"跨國巨頭密集掃貨中國創新藥，一季度BD交易狂攬600億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2623897395","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623897395?lang=zh_tw&edition=fundamental","pubTime":"2026-03-30 13:03","pubTimestamp":1774846980,"startTime":"0","endTime":"0","summary":"21世纪经济报道记者季媛媛今年一季度，中国创新药行业交出了一份亮眼的成绩单。国家药监局最新发布的数据显示，今年前三个月，我国创新药对外授权（BD）交易总额突破600亿美元，已接近2025年全年1357亿美元总额的一半。截至3月27日，2026年已批准10款创新药，其中国产创新药占据8款。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603303688535136.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603303688535136.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","159992","06978","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154808948","title":"雲頂新耀董事長斥資3270萬港元 於3月27日以每股38.12港元購入86萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=1154808948","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154808948?lang=zh_tw&edition=fundamental","pubTime":"2026-03-30 12:18","pubTimestamp":1774844337,"startTime":"0","endTime":"0","summary":"3月27日，云顶新耀董事长在公开市场进行了一次大规模股份增持。根据披露信息，此次交易涉及86万股公司股份，总金额高达3270万港元，每股成交价格为38.12港元。这一举动彰显了公司高层对未来发展的坚定信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","01952","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623398062","title":"雲頂新耀(01952)獲主要股東傅唯增持86萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2623398062","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623398062?lang=zh_tw&edition=fundamental","pubTime":"2026-03-30 12:18","pubTimestamp":1774844307,"startTime":"0","endTime":"0","summary":"智通财经APP讯，云顶新耀(01952)发布公告，公司董事会获非执行董事、董事会荣誉主席兼公司主要股东傅唯先生告知，于2026年3月27日，傅唯先生透过其控制的公司于市场购入86万股公司普通股，总代价约为3270万港元，平均价格约为每股股份38.12港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1421598.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"云顶新耀(01952)获主要股东傅唯增持86万股","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1161","01952","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623398522","title":"創新藥銷售收入目標增速上調至30%以上，恒瑞醫藥憑什麼?","url":"https://stock-news.laohu8.com/highlight/detail?id=2623398522","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623398522?lang=zh_tw&edition=fundamental","pubTime":"2026-03-30 11:59","pubTimestamp":1774843156,"startTime":"0","endTime":"0","summary":"长坡厚雪，真正的价值，终将被发现。","market":"fut","thumbnail":"https://img7.gelonghui.com/column/8.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/8.png?guru_height=540&guru_width=375"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4228133","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["LU2543165471.USD","BK0028","01276","LU1997245177.USD","LU2289578879.USD","LU1655091616.SGD","LU2580892862.HKD","LU2097828631.EUR","LU2488822045.USD","LU2148510915.USD","LU1997245094.SGD","BK0196","LU1820825898.SGD","BK0188","BK1191","BK1574","600276","LU1997244956.HKD","LU2097828474.EUR","LU2495084118.USD","BK0183","LU1064131003.USD","LU0359202008.SGD","LU1969619763.USD","LU1064130708.USD","LU1023057109.AUD","159992","BK1161","LU1580142542.USD","LU0359201612.USD","BK0239","LU0359201885.HKD","LU1255011170.USD","LU2328871848.SGD","LU0405327148.USD","LU2097828714.EUR","LU1146622755.USD","LU1328615791.USD","BK0012","LU2097828805.USD","LU1781817850.SGD","LU2580892789.USD","06978","LU0405327494.USD","BK0060","LU2097828557.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623678393","title":"27.5億美元！英硅智能牽手禮來，盤初暴拉15%！港股通創新藥ETF（520880）逆市摸高2.39%！榮昌生物績後飆漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2623678393","media":"新浪基金","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623678393?lang=zh_tw&edition=fundamental","pubTime":"2026-03-30 10:24","pubTimestamp":1774837440,"startTime":"0","endTime":"0","summary":"3月30日，A股港股深度调整，创新药一枝独秀！100%创新药研发标的——港股通创新药ETF华宝低开后直线拉升，一度摸高2.39%！重仓A股创新药的药ETF逆市涨逾1%。上个交易日，520880、562050单日暴涨5.51%、4.21%，双双创下历史最大单日涨幅。　　港股通创新药ETF华宝成份股英硅智能盘初暴拉近15%！　　值得一提的是，英硅智能于本月9日新入通，当日即被港股通创新药ETF华宝标的指数第一时间纳入成份股，先于其他多数同类指数。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-03-30/doc-inhstpik2965311.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0320765992.SGD","LU2112291526.USD","520880","LU2148510915.USD","IE0004445239.USD","LU0114720955.EUR","LU0786609619.USD","LU0094547139.USD","LU1061106388.HKD","LU1989771016.USD","LU2552382215.SGD","LU1323610961.USD","BK4599","LU0158827781.USD","LU1069344957.HKD","LU0882574139.USD","LLYZ","LU2265009873.SGD","LU0466842654.USD","LU1814569148.SGD","LU2328871848.SGD","LU2471134796.USD","LU2491050071.SGD","LU2271345857.HKD","IE00B4R5TH58.HKD","LU2896262040.SGD","LU0006306889.USD","IE00BJJMRZ35.SGD","LU1023059063.AUD","ELIS","LU1720051108.HKD","LU0316494557.USD","LU1548497426.USD","SG9999001176.SGD","SG9999015952.SGD","SG9999015978.USD","LU0471298694.HKD","LU2089984988.USD","LU2552382132.HKD","LU2236285917.USD","LU2168564065.EUR","LU0122379950.USD","LU0203201768.USD","LU2462157665.USD","LU1057294990.SGD","SG9999001176.USD","LU0106261372.USD","LU2028103732.USD","LU2211815571.USD","LU1551013342.USD","IE00BJJMRY28.SGD","LLY","LU2746668974.SGD","GB00BDT5M118.USD","LU1064131342.USD","LU2237443978.SGD","LU2756315664.SGD","LU0353189763.USD","IE00BKPKM429.USD","LU1868837136.USD","LU2023250504.SGD","LLYX","LU0787776722.HKD","LU2417539215.USD","LU1127390331.HKD","LU2361044949.HKD","LU1064130708.USD","LU0456855351.SGD","LU1551013425.SGD","LU2168563687.JPY","LU0210536198.USD","LU2089283258.USD","LU2168564222.USD","LU0943347566.SGD","LU2756315318.SGD","LU0323591593.USD","LU1093756168.USD","LU0234572021.USD","09995","BK4534","IE0009355771.USD","LU0640476718.USD","LU2602419157.SGD","BK4533","LU0432979614.USD","SG9999015945.SGD","LU1291159041.SGD","LU2361044865.SGD","IE00BK4W5M84.HKD","SGXZ99366536.SGD","SG9999014914.USD","LU0320765059.SGD","LU2087625088.SGD","LU1720051017.SGD","LU1868836914.USD","LU0882574055.USD","LU1983299246.USD","LU2089284900.SGD","LU1868836591.USD","LU0058720904.USD","LLII","SGXZ81514606.USD","IE00B4JS1V06.HKD","LU0096364046.USD","LU1035775433.USD","IE0005OL40V9.USD","BK4581","LU0823434740.USD","LU2264538146.SGD","LU1974910355.USD","IE0001KFT4U8.USD","IE00BJT1NW94.SGD","LU2456880835.USD","SG9999015986.USD","LU0109394709.USD","LU0256863902.USD","IE00BKDWB100.SGD","LU0225283273.USD","LU2237443382.USD","LU1280957306.USD","LU2063271972.USD","SG9999014880.SGD","SGXZ57979304.SGD","LU2237443549.SGD","LU0417517546.SGD","LU0689472784.USD","LU0708995401.HKD","LU2111349929.HKD","LU2471134879.HKD","BK4007","IE00B775H168.HKD","LU2552382058.USD","LU2471134952.CNY","IE00BJLML261.HKD","IE00BK4W5L77.USD","LU0823416689.USD","BK4516","IE00B2B36J28.USD","IE00BJJMRX11.SGD","IE0002141913.USD","IE00B1XK9C88.USD","LU0289739699.SGD","LU0238689110.USD","LU0964807845.USD","BK1161","LU2237443622.USD","LU1064131003.USD","688331","LU2746668461.USD","IE00BN29S564.USD","LU0109391861.USD","LU2106854487.HKD","LU1093756325.SGD","SG9999013999.USD","LU2213496289.HKD","LU2750360641.GBP","LU2750360997.AUD","LU1629891620.HKD","LU0158827948.USD","BK0239","LU2461242641.AUD","LU2491050154.USD","LU0823434583.USD","BK4588","LU2471134523.USD","LU0820562030.AUD","LU0353189680.USD","LU0683600562.USD","LU2237443465.HKD","LU0672654240.SGD","LU0256863811.USD","IE00BFTCPJ56.SGD","LU1868836757.USD","LU1232071149.USD","LU2237443895.HKD","LU0471298777.SGD","LU1145028129.USD","LU1804176565.USD","SG9999018865.SGD","LU2468319806.SGD","LU0061475181.USD","LU0820561818.USD","IE00B1BXHZ80.USD","LU1267930730.SGD","LU0354030438.USD","LU2491049909.HKD","LU0266013472.USD","LU2168564149.EUR","IE00BWXC8680.SGD","LU1917777945.USD","LU2488822045.USD","BK1574","LU2108987350.USD","SGXZ51526630.SGD","LU1712237335.SGD","LU0354030511.USD","LU1366192091.USD","SG9999014906.USD","LU0198837287.USD","SG9999018857.SGD","LU1969619763.USD","LU0203202063.USD","BK1583","LU2237438978.USD","SGXZ31699556.SGD","SG9999014898.SGD","LU0079474960.USD","LU1623119135.USD","LU1868837300.USD","LU2168564495.EUR","IE00BFSS8Q28.SGD","IE00B7KXQ091.USD","IE0004445015.USD","IE00BFSS7M15.SGD","LU0820561909.HKD","LU2023251221.USD","LU2361045086.USD","LU0385154629.USD","LU2023250330.USD","ELIL","LU2324357040.USD","LU2357305700.SGD","LU0097036916.USD","LU2360106947.USD","SG9999017495.SGD","BK4585","LU1988902786.USD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623678703","title":"部分創新藥概念股逆市上揚 榮昌生物(09995)漲4.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623678703","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623678703?lang=zh_tw&edition=fundamental","pubTime":"2026-03-30 10:23","pubTimestamp":1774837415,"startTime":"0","endTime":"0","summary":"金吾财讯 | 部分创新药概念股逆市上扬，荣昌生物 涨4.99%，康方生物涨4.75%，诺诚健华涨3.66%，先声药业涨2.73%，远大医药涨2.65%，和黄医药涨1.37%。据人民日报从国家药监局获悉，今年截至目前，我国创新药对外授权交易总额超过600亿美元，接近2025年全年的一半。今年截至3月27日，我国共批准上市10款创新药，其中8款是中国原创新药。2025年，我国批准创新药76个，创历史新高；创新药对外授权交易总金额突破1300亿美元，同样创历史新高。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250110/MmQ2MzI0NzdkYTM0MjU4ODU0NDE5OWM2MjQ0NmE1ZTExMDg1Mjk2Mjc3MDg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/MmQ2MzI0NzdkYTM0MjU4ODU0NDE5OWM2MjQ0NmE1ZTExMDg1Mjk2Mjc3MDg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1977637","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064131003.USD","LU2476274308.USD","BK1574","LU2476274720.SGD","00512","LU1720050803.USD","LU0417516571.SGD","LU1064130708.USD","LU0348735423.USD","LU0348784397.USD","LU2778985437.USD","LU0348783233.USD","LU2488822045.USD","BK1583","LU0348825331.USD","LU1961090484.USD","LU2399975544.HKD","BK1587","LU0561508036.HKD","LU0348767384.USD","LU0348766576.USD","LU1969619763.USD","LU1794554557.SGD","LU0348827113.USD","09926","BK1161","06978","IE00B543WZ88.USD","IE00B5MMRT66.SGD","09995","09969","00013","02096","LU0417516738.SGD","IE00BPRC5H50.USD","LU2328871848.SGD","BK1588","159992","LU0634319403.HKD","LU2148510915.USD","BK0239","LU0417516902.SGD","LU0540923850.HKD","BK1191","688331"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623362469","title":"港股榮昌生物升逾8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623362469","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623362469?lang=zh_tw&edition=fundamental","pubTime":"2026-03-30 10:02","pubTimestamp":1774836147,"startTime":"0","endTime":"0","summary":"每经AI快讯，3月30日，荣昌生物(09995.HK)涨超8%，截至发稿涨8.13%，报101.8港元，成交额2.84亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603303688402137.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603303688402137.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2328871848.SGD","BK4585","BK0239","688331","LU2488822045.USD","BK1574","LU2148510915.USD","BK1161","BK4588","LU1969619763.USD","BK1583","09995","LU1064131003.USD","VXUS","LU1064130708.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623625983","title":"315億現金「彈藥」就位，翰森製藥能否撬動全球創新藥市場？","url":"https://stock-news.laohu8.com/highlight/detail?id=2623625983","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623625983?lang=zh_tw&edition=fundamental","pubTime":"2026-03-30 09:51","pubTimestamp":1774835460,"startTime":"0","endTime":"0","summary":"2026年的春天，对于中国创新药行业而言，是一个检验“成色”的季节。3月29日，翰森制药（03692.HK）发布了2025年全年业绩报告。在医药行业经历资本寒冬洗礼、市场从“炒作估值”转向“验证现金流”的当下，这份财报不仅关乎一家企业，更被视为观察中国创新药头部企业能否穿越周期的窗口。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603303688387014.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603303688387014.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1191","BK1161","06978","159992","BK1589","BK1574","BK1583","03692"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":9,"totalSize":382,"code":"91000000","status":"200"}]}}